Yanis Boumber
机构: O'Neil Comprehensive Cancer Center, UAB
每年引用次数
引用次数
引用: 3,749
H-指数: 28
I10-指数 : 37
出版物: 116
An Sp1/Sp3 site polymorphism associated with hypermethylation of the candidate tumor suppressor gene RIL in cancer
Yanis A Boumber
2005
A polymorphic Sp1/Sp3 site confers methylation protection to the candidate tumor suppressor gene RIL in cancer
Yanis A Boumber , Yutaka Kondo , Xuqi Chen , Lanlan Shen
CANCER RESEARCH 66 ( 8)
2006
Knockout of the histone methyltransferase NSD1 leads to a decrease in cell proliferation and an increase in sensitivity to cisplatin in laryngeal squamous cell carcinoma
Iuliia A Topchu , Mariya V Tikhomirova , Emil R Bulatov , Zinaida I Abramova
Siberian Journal of Oncology 22 ( 2) 76 -84
1
2023
Design, synthesis and biological evaluation of 2-quinolyl-1,3-tropolone derivatives as new anti-cancer agents.
Evgeniy A Gusakov , Iuliia A Topchu , Aleksandra M Mazitova , Igor V Dorogan
RSC Advances 11 ( 8) 4555 -4571
2021
Synthesis, Structure, Ionochromic and Cytotoxic Properties of New 2-(Indolin-2-Yl)-1, 3-Tropolones
Yurii A Sayapin , Eugeny A Gusakov , Inna O Tupaeva , Alexander D Dubonosov
Available at SSRN 4941617
Design, synthesis and biological evaluation of 2-quinolyl-1, 3-tropolone derivatives as new anti-cancer agents
YA Sayapin , YA Boumber , ZI Abramova , TD Lam
Epigenetics in Cancer: What's the Future?
Jean Pierre J. Issa , Yanis Boumber
Oncology 25 ( 3) 220 -228
156
2011
Msi2 Regulates the Aggressiveness of Non-Small Cell Lung Cancer (NSCLC)
Yanis Boumber , University of New Mexico Albuquerque United States
2016
A methylation center within intron 1 of RIL predisposes to silencing, and is opposed by a polymorphic Sp1/Sp3 site
Marcos Estecio , Lanlan Shen , Jean-Pierre Issa , Saira Ahmed
Cancer Research 67 2843 -2843
2007
Musashi 2 (MSI2) expression as an independent prognostic biomarker in non-small cell lung cancer (NSCLC).
Alexander Deneka , Alexander Deneka , Zinaida Abramova , Elena Frantsiyants
Journal of Thoracic Disease 13 ( 3) 1370 -1379
2021
Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC).
Erica A Golemis , Ilya G Serebriiskii , Ilya G Serebriiskii , Essel Dulaimi
Oncogenesis 10 ( 3) 29 -29
2021
Cost of colon cancer care: Results of nationwide inpatient sample (NIS) data.
Pranshu Bansal , Ian Rabinowitz , Yanis Boumber , Dhruv Bansal
Journal of Clinical Oncology 35 692 -692
1
2017
Biomarkers for immune checkpoint inhibition in non–small cell lung cancer (NSCLC)
J. Nicholas Bodor , Yanis Boumber , Hossein Borghaei
Cancer 126 ( 2) 260 -270
31
2020
A Proteomics Analysis Reveals 9 Up-Regulated Proteins Associated with Altered Cell Signaling in Colon Cancer Patients
Oleg I. Kit , Dmitry I. Vodolazhsky , Denis S. Kutilin , Yaroslav S. Enin
Protein Journal 36 ( 6) 513 -522
7
2017
In Vitro Effects of the Combination of Idarubicin (IDA) with Suberoylanilide Hydroxamic Acid (SAHA) or Valproic Acid (VPA) in Leukemia Cell Lines.
Blanca Sanchez-Gonzalez , Koyu Hoshino , Carlos Bueso-Ramos , Hui Yang
Blood 104 ( 11) 1173 -1173
2004
Musashi 2 (MSI2) expression as an independent prognostic biomarker in non-small cell lung cancer (NSCLC).
Alexander Deneka , Leonid Kharin , Nikolay S. Karnaukhov , Mark Voloshin
Journal of Clinical Oncology 38 ( 15_suppl) e21583 -e21583
2020
Abstract B25: Anti-Mullerian hormone (AMH) supports epithelial identity and survival signaling in lung cancer
Tim N. Beck , Vladislav Korobeynikov , Alexander Kudinov , Rachel Georgeopoulos
Cancer Research 76
2016
Tumor-Targeted Drug Conjugates as an Emerging Novel Therapeutic Approach in Small Cell Lung Cancer (SCLC).
Alexander Y. Deneka , Yanis Boumber , Tim Beck , Erica A. Golemis
Cancers 11 ( 9) 1297
7
2019
An improved method of delivering a sclerosing agent for the treatment of malignant pleural effusion
Tim N. Beck , Alexander Y. Deneka , Louis Chai , Colin Kanach
BMC Cancer 19 ( 1) 614
2
2019
Case report: reinitiating pembrolizumab treatment after small bowel perforation
Tim N. Beck , Alexander E. Kudinov , Essel Dulaimi , Yanis Boumber
BMC Cancer 19 ( 1) 379
3
2019
Erica Golemis Jean-Pierre Issa Alexander Kudinov Alexander Deneka Ilya Serebriiskii Tim N Beck, M.D., Ph.D Anna Nikonova John Karanicolas Guillermo Garcia-Manero Pranshu Bansal Leonid Kharin Don L. Gibbons, MD, PhD Jorge Cortes Bernard Kwabi-Addo Vlad Korobeynikov Jaroslav Jelinek Gregory Gan Dong-Hua Yang Sanjeevani Arora, PhD Burger Jan